BioTime, LifeMap Acquiring XenneX | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – BioTime and its wholly owned subsidiary LifeMap Sciences announced today it is acquiring XenneX for an undisclosed amount.

XenneX will be merged into LifeMap. The deal is expected to close in 30 days.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genomic analysis of 200 bird species, and more.

The Australian High Court rules that isolated genetic material cannot be patented.

The startup incubator Y Combinator is launching a nonprofit research lab.

In Genome Research this week: vervet genome, tandem repeats affect gene expression in great apes, and more.